Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  OptimizeRx Corporation    OPRX

OPTIMIZERX CORPORATION

(OPRX)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

OPTIMIZERX CORP : Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 08:33am EST
Item 8.01 Other Events



On February 11, 2019, we issued a press release announcing our findings from a physician survey focused on prescription drug costs. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

99.1 Press release, dated February 11, 2019

                                       1

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on OPTIMIZERX CORPORATION
02/14OPTIMIZERX CORP : Results of Operations and Financial Condition, Financial State..
AQ
02/13OPTIMIZERX SETS FOURTH QUARTER AND F : 30 p.m. ET
GL
02/12OPTIMIZERX CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/11OptimizeRx Survey Shows Providers Believe They Have a Role in Discussing Care..
GL
02/08OPTIMIZERX CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/08OPTIMIZERX CORP : Entry into a Material Definitive Agreement, Change in Director..
AQ
02/07OPTIMIZERX : Introduces OptimizeMDs, a “Voice of the Physician” Mult..
AQ
02/07OptimizeRx Introduces OptimizeMDs, a “Voice of the Physician” Mul..
GL
01/29OPTIMIZERX CORP : Other Events (form 8-K)
AQ
01/29OptimizeRx Announces New Partnership with Health IT Pioneer lllumiCare
GL
More news
Financials ($)
Sales 2018 20,5 M
EBIT 2018 0,17 M
Net income 2018 0,22 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 640,50
P/E ratio 2019 109,02
Capi. / Sales 2018 7,52x
Capi. / Sales 2019 5,33x
Capitalization 154 M
Chart OPTIMIZERX CORPORATION
Duration : Period :
OptimizeRx Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 23,3 $
Spread / Average Target 82%
EPS Revisions
Managers
NameTitle
William J. Febbo Chief Executive Officer & Director
Miriam J. Paramore President
Gus D. Halas Chairman
Douglas Paul Baker CFO & Principal Accounting Officer
James D. Lang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
OPTIMIZERX CORPORATION16.77%154
JOHNSON & JOHNSON5.68%365 768
PFIZER-2.86%245 920
ROCHE HOLDING LTD.11.98%233 242
NOVARTIS7.19%228 685
MERCK AND COMPANY4.45%207 536